Literature DB >> 16041036

Probiotics reduce enterohemorrhagic Escherichia coli O157:H7- and enteropathogenic E. coli O127:H6-induced changes in polarized T84 epithelial cell monolayers by reducing bacterial adhesion and cytoskeletal rearrangements.

Philip M Sherman1, Kathene C Johnson-Henry, Helen P Yeung, Peter S C Ngo, Jacques Goulet, Thomas A Tompkins.   

Abstract

The aim of this study was to determine if probiotics reduce epithelial injury following exposure to Escherichia coli O157:H7 and E. coli O127:H6. The pretreatment of intestinal (T84) cells with lactic acid-producing bacteria reduced the pathogen-induced drop in transepithelial electrical resistance. These findings demonstrate that probiotics prevent epithelial injury induced by attaching-effacing bacteria.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16041036      PMCID： PMC1201237          DOI： 10.1128/IAI.73.8.5183-5188.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  35 in total

Review 1.  Probiotics and prebiotics: can regulating the activities of intestinal bacteria benefit health?

Authors:  G T Macfarlane; J H Cummings
Journal:  BMJ       Date:  1999-04-10

2.  Infection of T84 cells with enteropathogenic Escherichia coli alters barrier and transport functions.

Authors:  D J Philpott; D M McKay; P M Sherman; M H Perdue
Journal:  Am J Physiol       Date:  1996-04

3.  The human Lactobacillus acidophilus strain LA1 secretes a nonbacteriocin antibacterial substance(s) active in vitro and in vivo.

Authors:  M F Bernet-Camard; V Liévin; D Brassart; J R Neeser; A L Servin; S Hudault
Journal:  Appl Environ Microbiol       Date:  1997-07       Impact factor: 4.792

4.  Reduction of carriage of enterohemorrhagic Escherichia coli O157:H7 in cattle by inoculation with probiotic bacteria.

Authors:  T Zhao; M P Doyle; B G Harmon; C A Brown; P O Mueller; A H Parks
Journal:  J Clin Microbiol       Date:  1998-03       Impact factor: 5.948

5.  Alpha-actinin accumulation in epithelial cells infected with attaching and effacing gastrointestinal pathogens.

Authors:  A Ismaili; D J Philpott; M T Dytoc; R Soni; S Ratnam; P M Sherman
Journal:  J Infect Dis       Date:  1995-11       Impact factor: 5.226

6.  Antagonistic action of cells of Lactobacillus lactis toward Escherichia coli O157:H7 on refrigerated raw chicken meat.

Authors:  M M Brashears; S S Reilly; S E Gilliland
Journal:  J Food Prot       Date:  1998-02       Impact factor: 2.077

7.  Surface properties of the Vero cytotoxin-producing Escherichia coli O157:H7.

Authors:  P Sherman; R Soni; M Petric; M Karmali
Journal:  Infect Immun       Date:  1987-08       Impact factor: 3.441

8.  Factors involved in adherence of lactobacilli to human Caco-2 cells.

Authors:  J D Greene; T R Klaenhammer
Journal:  Appl Environ Microbiol       Date:  1994-12       Impact factor: 4.792

9.  Effect of oligomannoside-type glycopeptides in diarrheal disease of rabbits induced by Escherichia coli strain RDEC-1.

Authors:  P Sherman; R Soni; S Del Vedovo; J R Neeser
Journal:  FEMS Microbiol Lett       Date:  1989-10-01       Impact factor: 2.742

10.  Signal transduction pathways involved in enterohemorrhagic Escherichia coli-induced alterations in T84 epithelial permeability.

Authors:  D J Philpott; D M McKay; W Mak; M H Perdue; P M Sherman
Journal:  Infect Immun       Date:  1998-04       Impact factor: 3.441
View more
  71 in total

1.  Use of probiotics in gastrointestinal disorders: what to recommend?

Authors:  Elizabeth C Verna; Susan Lucak
Journal:  Therap Adv Gastroenterol       Date:  2010-09       Impact factor: 4.409

Review 2.  The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiota.

Authors:  Vanessa Liévin-Le Moal; Alain L Servin
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

3.  Probiotic treatment of rat pups normalises corticosterone release and ameliorates colonic dysfunction induced by maternal separation.

Authors:  Mélanie G Gareau; Jennifer Jury; Glenda MacQueen; Philip M Sherman; Mary H Perdue
Journal:  Gut       Date:  2007-03-05       Impact factor: 23.059

Review 4.  Probiotics for antibiotic-associated diarrhea: do we have a verdict?

Authors:  Iyad Issa; Rami Moucari
Journal:  World J Gastroenterol       Date:  2014-12-21       Impact factor: 5.742

5.  Active Hexose Correlated Compound (AHCC) promotes an intestinal immune response in BALB/c mice and in primary intestinal epithelial cell culture involving toll-like receptors TLR-2 and TLR-4.

Authors:  Jean-François Mallet; Émilie Graham; Barry W Ritz; Kohei Homma; Chantal Matar
Journal:  Eur J Nutr       Date:  2015-01-18       Impact factor: 5.614

Review 6.  NSAID enteropathy: could probiotics prevent it?

Authors:  Massimo Montalto; Antonella Gallo; Antonio Gasbarrini; Raffaele Landolfi
Journal:  J Gastroenterol       Date:  2012-08-09       Impact factor: 7.527

Review 7.  How bacterial pathogens eat host lipids: implications for the development of fatty acid synthesis therapeutics.

Authors:  Jiangwei Yao; Charles O Rock
Journal:  J Biol Chem       Date:  2015-02-03       Impact factor: 5.157

8.  Inhibitory effects of fermented brown rice on induction of acute colitis by dextran sulfate sodium in rats.

Authors:  Keiko Kataoka; Sachiko Ogasa; Tomomi Kuwahara; Yoshimi Bando; Mari Hagiwara; Hideki Arimochi; Shuusuke Nakanishi; Teruaki Iwasaki; Yoshinari Ohnishi
Journal:  Dig Dis Sci       Date:  2008-06       Impact factor: 3.199

Review 9.  Pathogenicity, host responses and implications for management of enterohemorrhagic Escherichia coli O157:H7 infection.

Authors:  Nathan K Ho; Aleah C Henry; Kathene Johnson-Henry; Philip M Sherman
Journal:  Can J Gastroenterol       Date:  2013       Impact factor: 3.522

10.  L. plantarum prevents enteroinvasive Escherichia coli-induced tight junction proteins changes in intestinal epithelial cells.

Authors:  Huanlong Qin; Zhongwei Zhang; Xiaomin Hang; Yanqun Jiang
Journal:  BMC Microbiol       Date:  2009-03-31       Impact factor: 3.605
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.